Clinical Trial Update: Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating IPM514 in Esophageal Squamous Cell Carcinoma to assess safety, tolerability, pharmacokinetics, and preliminary efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• IPM514

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING